                               SEQUENCE LISTING

<110> CELLA THERAPEUTICS, LLC
 
<120> DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN 
      APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND
      (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA)
      OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN
      OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC
      PROTEASE

<130> C4019.10002WO02

<140>
<141>

<150> 16/719,703
<151> 2019-12-18

<160> 22    

<170> PatentIn version 3.5

<210> 1
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Val Gly Asp Gly Gly Leu Phe Glu Lys Lys Leu 
1               5                   10      


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Asp Gly Gly Leu Gly 
1               5   


<210> 3
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
His His Ile Tyr Leu Gly Ala Val Asn Tyr Ile Tyr 
1               5                   10          


<210> 4
<211> 12
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
His His Ile Tyr Leu Gly Ala Thr Asn Tyr Ile Tyr 
1               5                   10          


<210> 5
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Tyr Leu Gly Ala 
1               


<210> 6
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Ile Tyr Leu Gly Ala 
1               5   


<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Tyr Leu Gly Ala Val 
1               5   


<210> 8
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
His Ile Tyr Leu Gly Ala 
1               5       


<210> 9
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Ile Tyr Leu Gly Ala Val 
1               5       


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
His Ile Tyr Leu Gly Ala Val 
1               5           


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Ile Tyr Leu Gly Ala Val Asn 
1               5           


<210> 12
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
His His Ile Tyr Leu Gly Ala 
1               5           


<210> 13
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Tyr Leu Gly Ala Val Asn Tyr 
1               5           


<210> 14
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
His His Ile Tyr Leu Gly Ala Val 
1               5               


<210> 15
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Tyr Leu Gly Ala Val Asn Tyr Ile 
1               5               


<210> 16
<211> 20
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
gaaacgaacu gcacccggau                                                   20


<210> 17
<211> 19
<212> RNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 17
uagcgacuaa acacaucaa                                                    19


<210> 18
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Asp Gly Gly Leu 
1               


<210> 19
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Tyr Leu Gly Ala Val Asn 
1               5       


<210> 20
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
His Ile Tyr Leu Gly Ala Val Asn 
1               5               


<210> 21
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term resin

<220>
<221> MOD_RES
<222> (2)..(3)
<223> Lys(Boc)

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Glu(tBu)

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Asp(tBu)

<220>
<223> C-term CO2(CH2-CH2-O)n-CH2-CH2-NH2

<400> 21
Leu Lys Lys Glu Phe Leu Gly Gly Asp Gly Val 
1               5                   10      


<210> 22
<211> 11
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<223> N-term resin

<220>
<221> MOD_RES
<222> (2)..(3)
<223> Lys(Cbz)

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Glu(Bn)

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Asp(Bn)

<220>
<223> C-term CO2(CH2-CH2-O)n-CH2-CH2-OH

<400> 22
Leu Lys Lys Glu Phe Leu Gly Gly Asp Gly Val 
1               5                   10      


